Lifecare strengthens miniaturization roadmap with new patent applications

Lifecare ASA has filed new patent applications in Europe and the United States for surface acoustic wave (SAW) sensing technology, which will enhance osmotic glucose measurement. This move strengthens Lifecare's miniaturization roadmap for implantable sensors, complementing its current reliance on piezoresistive pressure sensors for its first product generation.

SAW sensors, tiny chips detecting surface vibrations, leverage Lifecare's osmotic principle where glucose levels are reflected as pressure changes. This technology, along with the licensed Nano Tunneling Resistor technology, offers an alternative for future miniaturization, promising improved sensitivity and supporting standardized production methods for faster development.

The European application, filed with academic partner Johann Wolfgang Goethe University Frankfurt, is set for publication in the European Patent Bulletin on September 24, 2025. Lifecare's sensor technology is designed for monitoring a wide range of analytes and molecules in humans and pets.